According to the Pharmaceutical Research and Manufacturers of America (PhRMA), there are 264 vaccines in development to prevent and treat diseases.

GlaxoSmithKline has filed its shingles vaccine Shingrix for U.S. regulatory approval, bringing the potential $1 billion-a-year seller a step closer to market.